Citadel Advisors’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,000
Closed -$119K 15763
2025
Q1
$119K Sell
14,000
-44,300
-76% -$244K ﹤0.01% 11212
2024
Q4
$203K Buy
58,300
+2,500
+4% +$3.53K ﹤0.01% 10433
2024
Q3
$51.9K Buy
55,800
+4,700
+9% +$4.19K ﹤0.01% 11866
2024
Q2
$44.8K Buy
51,100
+44,300
+651% +$42K ﹤0.01% 11889
2024
Q1
$7.21K Sell
6,800
-19,600
-74% -$20.4K ﹤0.01% 13628
2023
Q4
$25.4K Buy
26,400
+3,600
+16% +$3.49K ﹤0.01% 12409
2023
Q3
$21.9K Buy
22,800
+11,700
+105% +$12.7K ﹤0.01% 12557
2023
Q2
$13.4K Sell
11,100
-4,200
-27% -$5.32K ﹤0.01% 13040
2023
Q1
$19.3K Buy
15,300
+7,400
+94% +$12.1K ﹤0.01% 13093
2022
Q4
$14.7K Buy
+7,900
New +$15.5K ﹤0.01% 13379
2022
Q3
Sell
-13,700
Closed -$29K 13809
2022
Q2
$29K Sell
13,700
-20,800
-60% -$66.8K ﹤0.01% 12249
2022
Q1
$158K Buy
34,500
+14,600
+73% +$81.4K ﹤0.01% 11799
2021
Q4
$128K Buy
19,900
+6,200
+45% +$37.2K ﹤0.01% 12461
2021
Q3
$85K Buy
+13,700
New +$94.2K ﹤0.01% 13026
2021
Q2
Sell
-15,100
Closed -$146K 14595
2021
Q1
$146K Buy
+15,100
New +$139K ﹤0.01% 12078
2018
Q4
Sell
-10,800
Closed -$42K 9876
2018
Q3
$42K Buy
+10,800
New +$46K ﹤0.01% 8837
2016
Q2
Sell
-32,900
Closed -$168K 7513
2016
Q1
$168K Buy
32,900
+19,700
+149% +$129K ﹤0.01% 5765
2015
Q4
$118K Buy
13,200
+7,000
+113% +$252K ﹤0.01% 6510
2015
Q3
$237K Buy
6,200
+1,400
+29% +$69.2K ﹤0.01% 5912
2015
Q2
$222K Sell
4,800
-800
-14% -$32.1K ﹤0.01% 6182
2015
Q1
$211K Buy
5,600
+1,900
+51% +$75.4K ﹤0.01% 6112
2014
Q4
$149K Buy
+3,700
New +$125K ﹤0.01% 6295

Other funds holding CMRX

Citadel Advisors's CMRX Position: Q2 2025 in Review

Citadel Advisors sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 82,989 shares — an estimated $706K sold.

Citadel Advisors first reported a position in CMRX in Q4 2013 and held it in 46 quarters. The position peaked at $28.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

  • Citadel Advisors reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 82,989 Chimerix, Inc. shares in Q2 2025, an estimated $706K.
  • Citadel Advisors first reported a position in Chimerix, Inc. in Q4 2013 and held it in 46 quarters.
  • Citadel Advisors's Chimerix, Inc. position peaked at $28.3M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.